GCP
AMAG

GSA Capital Partners’s AMAG Pharmaceuticals AMAG Stock Holding History

GSA Capital Partners’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-52,700
Closed -$679K – 1862
2019
Q1 		$679K Sell
52,700
-541
-1% -$8.06K 0.07% 510
2018
Q4 		$809K Sell
53,241
-32,003
-38% -$610K 0.09% 313
2018
Q3 		$1.71M Buy
85,244
+29,100
+52% +$662K 0.09% 330
2018
Q2 		$1.09M Buy
+56,144
New +$1.24M 0.05% 700
2018
Q1 		– Sell
-100,561
Closed -$1.33M – 1919
2017
Q4 		$1.33M Sell
100,561
-32,709
-25% -$493K 0.08% 426
2017
Q3 		$2.46M Buy
133,270
+40,270
+43% +$751K 0.17% 92
2017
Q2 		$1.71M Buy
93,000
+46,200
+99% +$915K 0.11% 217
2017
Q1 		$1.05M Buy
46,800
+14,092
+43% +$337K 0.06% 607
2016
Q4 		$1.14M Sell
32,708
-1,152
-3% -$34.4K 0.07% 493
2016
Q3 		$830K Buy
33,860
+24,300
+254% +$607K 0.04% 724
2016
Q2 		$229K Sell
9,560
-1,840
-16% -$42.2K 0.01% 1514
2016
Q1 		$267K Buy
+11,400
New +$271K 0.02% 1360
2015
Q4 		– Sell
-28,465
Closed -$1.13M – 2042
2015
Q3 		$1.13M Buy
28,465
+1,567
+6% +$97.3K 0.06% 554
2015
Q2 		$1.86M Buy
26,898
+11,988
+80% +$754K 0.07% 422
2015
Q1 		$815K Buy
14,910
+8,014
+116% +$382K 0.03% 1034
2014
Q4 		$294K Buy
+6,896
New +$249K 0.02% 1275
2014
Q2 		– Sell
-14,615
Closed -$283K – 2021
2014
Q1 		$283K Sell
14,615
-300
-2% -$6.37K 0.02% 1171
2013
Q4 		$362K Buy
+14,915
New +$351K 0.03% 1078

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

GSA Capital Partners's AMAG Position: Q2 2019 in Review

GSA Capital Partners sold out of AMAG Pharmaceuticals (AMAG) in Q2 2019, closing a stake of 52,700 shares — an estimated $679K sold.

GSA Capital Partners first reported a position in AMAG in Q4 2013 and held it in 18 quarters. The position peaked at $2.46M in Q3 2017. 170 funds tracked by Wall St. Rank hold AMAG as of Q2 2019.

  • GSA Capital Partners reported no remaining AMAG Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • GSA Capital Partners sold 52,700 AMAG Pharmaceuticals shares in Q2 2019, an estimated $679K.
  • GSA Capital Partners first reported a position in AMAG Pharmaceuticals in Q4 2013 and held it in 18 quarters.
  • GSA Capital Partners's AMAG Pharmaceuticals position peaked at $2.46M in Q3 2017.
  • 170 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2019.

Based on GSA Capital Partners's 13F filing for Q2 2019, filed 6 Aug 2019.